1.39
price down icon0.71%   -0.01
 
loading
Schlusskurs vom Vortag:
$1.40
Offen:
$1.37
24-Stunden-Volumen:
769.52K
Relative Volume:
0.49
Marktkapitalisierung:
$351.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-125.04M
KGV:
-1.6951
EPS:
-0.82
Netto-Cashflow:
$-122.99M
1W Leistung:
+19.83%
1M Leistung:
-6.08%
6M Leistung:
-47.35%
1J Leistung:
-26.06%
1-Tages-Spanne:
Value
$1.325
$1.42
1-Wochen-Bereich:
Value
$1.13
$1.55
52-Wochen-Spanne:
Value
$1.01
$3.45

Erasca Inc Stock (ERAS) Company Profile

Name
Firmenname
Erasca Inc
Name
Telefon
(858) 465-6511
Name
Adresse
10835 ROAD TO THE CURE, SUITE 140, SAN DIEGO
Name
Mitarbeiter
129
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ERAS's Discussions on Twitter

Vergleichen Sie ERAS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ERAS
Erasca Inc
1.39 351.25M 0 -125.04M -122.99M -0.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Erasca Inc Stock (ERAS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-26 Eingeleitet Raymond James Outperform
2024-11-18 Eingeleitet Jefferies Buy
2024-03-11 Eingeleitet CapitalOne Overweight
2024-01-05 Herabstufung BofA Securities Buy → Neutral
2023-10-11 Eingeleitet H.C. Wainwright Buy
2023-03-30 Eingeleitet Mizuho Buy
2023-02-24 Eingeleitet Goldman Buy
2023-02-03 Hochstufung Morgan Stanley Equal-Weight → Overweight
Alle ansehen

Erasca Inc Aktie (ERAS) Neueste Nachrichten

pulisher
Apr 25, 2025

Erasca, Inc: Carving A Different Niche In RAS Signaling (NASDAQ:ERAS) - Seeking Alpha

Apr 25, 2025
pulisher
Apr 24, 2025

Check out these key findings about Erasca Inc (ERAS) - Sete News

Apr 24, 2025
pulisher
Apr 24, 2025

Analytical Overview: Erasca Inc (ERAS)’s Ratios Tell a Financial Story - DWinneX

Apr 24, 2025
pulisher
Apr 23, 2025

Erasca Inc (ERAS) may enjoy gains as insiders got busy in the recent days - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

ERAS’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Apr 23, 2025
pulisher
Apr 23, 2025

Geode Capital Management LLC Grows Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 23, 2025
pulisher
Apr 21, 2025

JPMorgan Chase & Co. Lowers Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 21, 2025
pulisher
Apr 16, 2025

Is Erasca Inc. (NASDAQ:ERAS) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Yahoo Finance

Apr 16, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Acquires New Stake in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

Vanguard Group Inc. Sells 614,840 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

KLP Kapitalforvaltning AS Makes New $69,000 Investment in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Erasca, Inc. (NASDAQ:ERAS) Shares Acquired by American Century Companies Inc. - Defense World

Apr 11, 2025
pulisher
Apr 08, 2025

Erasca stock hits 52-week low at $1.02 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

Erasca stock hits 52-week low at $1.02 amid market challenges - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Erasca Slides As Insider Purchases Lose Another US$84k - Yahoo Finance

Apr 08, 2025
pulisher
Apr 08, 2025

Erasca (NASDAQ:ERAS) vs. Merck KGaA (OTCMKTS:MKGAF) Head-To-Head Contrast - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Erasca Inc (NASDAQ: ERAS) Stock Sentiment: What’s Wall Street Saying? - stocksregister.com

Apr 07, 2025
pulisher
Apr 05, 2025

Thrivent Financial for Lutherans Sells 29,263 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

Erasca, Inc. (NASDAQ:ERAS) Receives $4.83 Consensus Price Target from Brokerages - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

Teacher Retirement System of Texas Buys 12,345 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Erasca Insiders Lose Out As Stock Sinks To US$1.21 - simplywall.st

Apr 02, 2025
pulisher
Apr 01, 2025

Erasca stock hits 52-week low at $1.23 amid market challenges - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Erasca stock hits 52-week low at $1.23 amid market challenges By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Mar 30, 2025

Erasca (NASDAQ:ERAS) Coverage Initiated by Analysts at Raymond James - MarketBeat

Mar 30, 2025
pulisher
Mar 30, 2025

Erasca, Inc. (NASDAQ:ERAS) Shares Bought by Swiss National Bank - Defense World

Mar 30, 2025
pulisher
Mar 27, 2025

Erasca (NASDAQ:ERAS) Now Covered by Analysts at Raymond James - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Raymond James sets $5 target for Erasca stock, cites valuation gap By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Raymond James Initiates Coverage of Erasca (ERAS) with Outperform Recommendation - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Raymond James sets $5 target for Erasca stock, cites valuation gap - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

Raymond James Initiates Erasca at Outperform With $5 Price Target - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Erasca initiated with an Outperform at Raymond James - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Charles Schwab Investment Management Inc. Buys 39,066 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting - The Manila Times

Mar 25, 2025
pulisher
Mar 25, 2025

Game-Changing Cancer Treatments: Erasca Reveals 3 Novel Drug Breakthroughs at AACR 2025 - Stock Titan

Mar 25, 2025
pulisher
Mar 24, 2025

Bank of New York Mellon Corp Grows Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

What is HC Wainwright’s Estimate for Erasca FY2029 Earnings? - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

The Goldman Sachs Group Has Lowered Expectations for Erasca (NASDAQ:ERAS) Stock Price - Defense World

Mar 23, 2025
pulisher
Mar 23, 2025

Erasca (NASDAQ:ERAS) Earns “Buy” Rating from HC Wainwright - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results - The Manila Times

Mar 21, 2025
pulisher
Mar 21, 2025

Erasca, Inc. Reports 2024 Financial and Strategic Progress - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Erasca Inc. (ERAS) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

ERASCA Earnings Results: $ERAS Reports Quarterly Earnings - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Erasca, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Erasca's $440M War Chest Powers Two Groundbreaking Cancer Drugs Into 2025 Trials - StockTitan

Mar 20, 2025
pulisher
Mar 19, 2025

Erasca (ERAS) Expected to Announce Earnings on Wednesday - Defense World

Mar 19, 2025
pulisher
Mar 10, 2025

Brokerages Set Erasca, Inc. (NASDAQ:ERAS) Price Target at $5.70 - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Morgan Stanley Reaffirms Overweight Rating for Erasca (NASDAQ:ERAS) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Boosts Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Erasca’s Promising Oncology Advances: Buy Rating Backed by Strong Market Potential and Competitive Edge - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Erasca, Inc. (NASDAQ:ERAS) Shares Acquired by New York State Common Retirement Fund - Defense World

Mar 07, 2025

Finanzdaten der Erasca Inc-Aktie (ERAS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):